AUD5.01
0.91% today
Australia, Sep 04, 05:41 am CET
ISIN
AU000000MPL3
Symbol
MPL
Sector
Industry

Medibank Private Target price 2025 - Analyst rating & recommendation

Medibank Private Classifications & Recommendation:

Buy
36%
Hold
64%

Medibank Private Price Target

Target Price AUD5.15
Price AUD4.96
Potential
Number of Estimates 11
11 Analysts have issued a price target Medibank Private 2026 . The average Medibank Private target price is AUD5.15. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 14 analysts: 5 Analysts recommend Medibank Private to buy, 9 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Medibank Private stock has an average upside potential 2026 of . Most analysts recommend the Medibank Private stock at Hold.

Sales and Margin forecast 2026, 2027 to 2029

Create a premium account to unlock analyst estimates. Learn more

Jun '25 2026
Estimates
Revenue Billion AUD 8.16 9.16
4.61% 12.35%
EBITDA Margin 10.14% 8.38%
1.52% 17.35%
Net Margin 6.14% 7.26%
2.79% 18.22%

7 Analysts have issued a sales forecast Medibank Private 2026 . The average Medibank Private sales estimate is

AUD9.2b
Unlock
. This is
12.35% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
AUD9.7b 19.03%
Unlock
, the lowest is
AUD8.8b 7.65%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 AUD8.2b 4.61%
2026
AUD9.2b 12.35%
Unlock
2027
AUD9.6b 4.64%
Unlock
2028
AUD10.0b 4.45%
Unlock
2029
AUD10.1b 0.58%
Unlock

5 Analysts have issued an Medibank Private EBITDA forecast 2026. The average Medibank Private EBITDA estimate is

AUD768m
Unlock
. This is
7.18% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
AUD798m 3.51%
Unlock
, the lowest is
AUD745m 9.94%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 AUD827m 3.01%
2026
AUD768m 7.18%
Unlock
2027
AUD792m 3.16%
Unlock

EBITDA Margin

2025 10.14% 1.52%
2026
8.38% 17.35%
Unlock
2027
8.26% 1.43%
Unlock

12 Medibank Private Analysts have issued a net profit forecast 2026. The average Medibank Private net profit estimate is

AUD665m
Unlock
. This is
32.75% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
AUD752m 50.13%
Unlock
, the lowest is
AUD618m 23.41%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 AUD501m 1.69%
2026
AUD665m 32.75%
Unlock
2027
AUD697m 4.81%
Unlock
2028
AUD720m 3.39%
Unlock
2029
AUD780m 8.26%
Unlock

Net Margin

2025 6.14% 2.79%
2026
7.26% 18.22%
Unlock
2027
7.27% 0.14%
Unlock
2028
7.19% 1.10%
Unlock
2029
7.74% 7.65%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2029

Create a premium account to unlock analyst estimates. Learn more

Jun '25 2026
Estimates
Earnings Per Share AUD 0.18 0.24
0.00% 33.33%
P/E 20.80
EV/Sales 1.45

12 Analysts have issued a Medibank Private forecast for earnings per share. The average Medibank Private EPS is

AUD0.24
Unlock
. This is
33.33% higher
Unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
AUD0.27 50.00%
Unlock
, the lowest is
AUD0.22 22.22%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 AUD0.18 0.00%
2026
AUD0.24 33.33%
Unlock
2027
AUD0.25 4.17%
Unlock
2028
AUD0.26 4.00%
Unlock
2029
AUD0.28 7.69%
Unlock

P/E ratio

Current 27.89 30.05%
2026
20.80 25.42%
Unlock
2027
19.84 4.62%
Unlock
2028
19.19 3.28%
Unlock
2029
17.73 7.61%
Unlock

Based on analysts' sales estimates for 2026, the Medibank Private stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 1.63 17.27%
2026
1.45 10.92%
Unlock
2027
1.39 4.44%
Unlock
2028
1.33 4.27%
Unlock
2029
1.32 0.57%
Unlock

P/S ratio

Current 1.69 23.58%
2026
1.50 10.99%
Unlock
2027
1.43 4.43%
Unlock
2028
1.37 4.26%
Unlock
2029
1.36 0.58%
Unlock

Current Medibank Private Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
JEFFERIES
Locked
Locked
Locked Jul 16 2025
MACQUARIE RESEARCH
Locked
Locked
Locked Jul 13 2025
MACQUARIE RESEARCH
Locked
Locked
Locked Mar 18 2025
JEFFERIES
Locked
Locked
Locked Mar 05 2025
JEFFERIES
Locked
Locked
Locked Feb 26 2025
Analyst Rating Date
Locked
JEFFERIES:
Locked
Locked
Jul 16 2025
Locked
MACQUARIE RESEARCH:
Locked
Locked
Jul 13 2025
Locked
MACQUARIE RESEARCH:
Locked
Locked
Mar 18 2025
Locked
JEFFERIES:
Locked
Locked
Mar 05 2025
Locked
JEFFERIES:
Locked
Locked
Feb 26 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today